5 Best Russell 2000 Stocks To Buy According To Hedge Funds
In this article, we discuss 5 best Russell 2000 stocks to buy.
Intra-Cellular Therapies Inc. (ITCI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 2,255,555 | $161,542,849 | 2.23% | |
| 2. | Deep Track Capital David Kroin | 2,000,000 | $143,240,000 | -24% | 4.78% |
| 3. | Holocene Advisors Brandon Haley | 1,261,857 | $90,374,198 | -12% | 0.35% |
| 4. | Suvretta Capital Management Aaron Cowen | 1,165,948 | $83,505,196 | -15% | 3.77% |
| 5. | Polar Capital Brian Ashford-Russell And Tim Woolley | 928,745 | $66,516,717 | -8% | 0.4% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.60 | 49,500 | Director | 4,743,770 | 2020-09-14 | Filing | |
| $28.08 | 21,000 | Director | 4,694,270 | 2020-09-11 | Filing | |
| $11.00 | 6,240 | Large Shareholder, Director | 4,673,270 | 2019-09-10 | Filing | |
| $10.58 | 320,095 | Large Shareholder, Director | 4,667,030 | 2019-09-10 | Filing | |
| $9.59 | 155,116 | Large Shareholder, Director | 4,346,935 | 2019-09-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $67.33 | 306 | 1,050,309 | 2024-03-11 | Filing | ||
| $66.81 | 1,590 | 1,050,615 | 2024-03-11 | Filing | ||
| $65.90 | 4,128 | 1,052,205 | 2024-03-11 | Filing | ||
| $64.80 | 14,541 | 1,056,333 | 2024-03-11 | Filing | ||
| $66.93 | 8,754 | 1,050,309 | 2024-03-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,457,694 | $820,600,049 | 0.06% | |
| 2. | 9,094,302 | $651,333,910 | 0.01% | |
| 3. | 8,193,544 | $586,821,618 | 0.01% | |
| 4. | 3,627,308 | $259,787,799 | 1.43% | |
| 5. | 3,066,400 | $219,615,568 | 3.35% |
News See All
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q4 2023 Earnings Call Transcript
Intra-Cellular Therapies, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.44. Intra-Cellular Therapies, Inc.
16 Best Mid-Cap Growth Stocks To Buy Now
Investors are hopeful that small- and mid-cap stocks will experience a broader rally this year after getting hammered for most part of the previous year as all eyes remain focused on the Magnificent Seven...
5 Best Psychedelic Stocks to Buy
COMPASS Pathways plc (NASDAQ:CMPS) is a mental healthcare company based in the United Kingdom.
5 Most Promising Psychedelic Stocks According to Hedge Funds
In this piece, we will take a look at the five most promising psychedelic stocks according to hedge funds.
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to the Intra-Cellular Therapies 3Q 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q2 2023 Earnings Call Transcript
Operator: Good morning. And welcome to Intra-Cellular Therapies Second Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2023 Earnings Call Transcript
Operator: Good morning and welcome to Intra-Cellular Therapies First Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.
12 Most Promising Healthcare Stocks According to Analysts
In this article, we will take a look at the 12 most promising healthcare stocks according to analysts.
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q4 2022 Earnings Call Transcript
Operator: Thank you for standing by and welcome to the Intra-Cellular Therapies Fourth Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
